Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

October 8, 2024 9:17 AM EDT Send to a Friend
Stifel analyst Dae Gon ha reiterated a Buy rating and $74.00 price target on Soleno Therapeutics Inc. (NASDAQ: SLNO).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login